Daily Sepsis Research Analysis
Three studies advance sepsis science across mechanisms, biomarkers, and clinical diagnostics. A translational study identifies IL-40 as a severity biomarker and therapeutic target via NETosis blockade; a mechanistic paper reveals lactate-dependent H3K14 lactylation driving endothelial ferroptosis in sepsis-associated ARDS; and a meta-analysis clarifies how SIC, JAAM-DIC, and ISTH-DIC scoring systems differ for identifying coagulopathy and predicting mortality.
Summary
Three studies advance sepsis science across mechanisms, biomarkers, and clinical diagnostics. A translational study identifies IL-40 as a severity biomarker and therapeutic target via NETosis blockade; a mechanistic paper reveals lactate-dependent H3K14 lactylation driving endothelial ferroptosis in sepsis-associated ARDS; and a meta-analysis clarifies how SIC, JAAM-DIC, and ISTH-DIC scoring systems differ for identifying coagulopathy and predicting mortality.
Research Themes
- Cytokine-driven NETosis and translational biomarker development (IL-40)
- Epigenetic lactylation–ferroptosis axis in sepsis-associated ARDS
- Comparative performance of DIC scoring systems in sepsis
Selected Articles
1. Inhibition of Interleukin-40 prevents multi-organ damage during sepsis by blocking NETosis.
Two independent sepsis cohorts showed elevated IL-40 at admission correlating with PCT, CRP, lactate/LDH, and SOFA, enabling early-death stratification. Genetic IL-40 inhibition/knockout reduced NETosis and mitigated multi-organ damage in experimental sepsis, indicating IL-40 as both a prognostic biomarker and therapeutic target.
Impact: Bridges clinical biomarker discovery with mechanistic validation linking IL-40 to NETosis and organ injury, opening a targeted therapeutic avenue in sepsis.
Clinical Implications: IL-40 measurement could aid early risk stratification; anti–IL-40 strategies or NETosis-targeted interventions warrant clinical investigation for organ-protective effects.
Key Findings
- IL-40 levels at admission were elevated in two independent sepsis cohorts and correlated with PCT, CRP, lactate/LDH, and SOFA.
- IL-40 enabled stratification of early death risk among critically ill sepsis patients.
- Genetic inhibition/knockout of IL-40 reduced NETosis and attenuated multi-organ injury in experimental sepsis.
Methodological Strengths
- Dual independent patient cohorts with concordant biomarker–severity correlations
- Mechanistic validation using genetic knockout linking IL-40 to NETosis and organ protection
Limitations
- Sample sizes and detailed cohort methodologies are not specified in the abstract
- Therapeutic efficacy is shown preclinically; causal benefit in humans remains unproven
Future Directions: Validate IL-40 prognostic thresholds in multicenter cohorts; develop and test IL-40/NETosis-targeted agents in early-phase sepsis trials.
Despite intensive clinical and scientific efforts, the mortality rate of sepsis remains high due to the lack of precise biomarkers for patient stratification and therapeutic guidance. Interleukin 40 (IL-40), a novel cytokine with immune regulatory functions in human diseases, was elevated at admission in two independent cohorts of patients with sepsis. High levels of secreted IL-40 in septic patients were positively correlated with PCT, CRP, lactate (LDH), and Sequential Organ Failure Assessment (SOFA) scores, in which IL-40 levels were used to stratify the early death of critically ill patients with sepsis. Moreover, genetic knockout of IL-40 (IL-40
2. H3K14la drives endothelial dysfunction in sepsis-induced ARDS by promoting SLC40A1/transferrin-mediated ferroptosis.
In septic mice, lactate-driven H3K14 lactylation increases in pulmonary ECs, promoting ferroptosis via transcriptional upregulation at TFRC and SLC40A1 promoters. Inhibiting glycolysis reduced H3K14la and EC activation, highlighting a glycolysis–lactylation–ferroptosis axis as a therapeutic target in sepsis-associated ARDS.
Impact: First demonstration linking histone lactylation to endothelial ferroptosis in sepsis-associated ARDS, integrating multi-omics and epigenomic mapping.
Clinical Implications: Identifies potential targets (glycolysis, H3K14 lactylation, ferroptosis effectors) for pharmacologic modulation in septic ARDS; supports exploring ferroptosis inhibitors or lactylation modulators.
Key Findings
- Septic mouse lungs exhibited elevated lactate and H3K14 lactylation, especially in pulmonary endothelial cells.
- Glycolysis inhibition decreased H3K14la and endothelial activation, linking metabolism to epigenetic regulation.
- H3K14la was enriched at TFRC and SLC40A1 promoters, promoting ferroptosis and vascular dysfunction in sepsis-induced lung injury.
Methodological Strengths
- Integrative lactylome and proteome profiling coupled with EC-focused Cut&Tag
- In vivo validation in septic mouse lungs linking metabolism to epigenetic control
Limitations
- Preclinical mouse model without human validation limits direct clinical generalizability
- Therapeutic modulation of H3K14la/ferroptosis was not tested in interventional in vivo studies
Future Directions: Validate H3K14la targets in human septic ARDS tissues; evaluate pharmacologic inhibitors of lactylation/ferroptosis in relevant models and early-phase trials.
Pulmonary endothelial cell (EC) activation is a key factor in acute respiratory distress syndrome (ARDS). In sepsis, increased glycolysis leads to lactate buildup, which induces lysine lactylation (Kla) on histones and other proteins. However, the role of protein lactylation in EC dysfunction during sepsis-induced ARDS remains unclear. Integrative lactylome and proteome analyses were performed to identify the global lactylome profile in the lung tissues of septic mice. Cut&Tag analysis was used to identify the transcriptional targets of histone H3 lysine 14 lactylation (H3K14la) in ECs. Septic mice presented elevated levels of lactate and H3K14la in lung tissues, particularly in pulmonary ECs. Suppressing glycolysis reduced both H3K14la and EC activation, suggesting a link between glycolysis and lactylation. Moreover, H3K14la was enriched at promoter regions of ferroptosis-related genes such as transferrin receptor (TFRC) and solute carrier family 40 member 1 (SLC40A1), which contributed to EC activation and lung injury under septic conditions. For the first time, we reported the role of lactate-dependent H3K14 lactylation in regulating EC ferroptosis to promote vascular dysfunction during sepsis-induced lung injury. Our findings suggest that manipulation of the glycolysis/H3K14la/ferroptosis axis may provide novel therapeutic approaches for sepsis-associated ARDS.
3. A comparison of disseminated intravascular coagulation scoring systems and their performance to predict mortality in sepsis patients: A systematic review and meta-analysis.
Across 21 studies (n=9319), SIC and JAAM-DIC showed higher sensitivity for identifying coagulopathy and predicting outcomes, while ISTH-DIC provided higher specificity. The proposed approach is to use SIC/JAAM-DIC for early identification and ISTH-DIC for later confirmation and outcome prediction.
Impact: Provides quantitative guidance on which DIC score to use and when in sepsis, enabling more timely recognition and targeted anticoagulant strategies.
Clinical Implications: Adopt SIC or JAAM-DIC for early screening of sepsis-induced coagulopathy, reserving ISTH-DIC for confirmation and high-specificity prognostication.
Key Findings
- Pooled DIC positivity: ISTH-DIC 28%, JAAM-DIC 55%, SIC 57% among 9319 sepsis patients.
- Mortality rates in positive cases: ISTH-DIC 44%, JAAM-DIC 37%, SIC 35%.
- Sensitivity/specificity for mortality prediction: ISTH-DIC 0.43/0.81; JAAM-DIC 0.73/0.46; SIC 0.71/0.49.
Methodological Strengths
- PROSPERO登録の事前計画と4データベースの系統検索
- ランダム効果モデルと地理/病期別のサブグループ解析
Limitations
- Heterogeneity across studies in sepsis definitions and timing of DIC assessment
- Limited individual patient data may constrain adjustment for confounders
Future Directions: Prospective head-to-head validation of DIC scores with standardized sepsis phenotyping and evaluation of biomarker-anchored anticoagulant strategies.
BACKGROUND: Disseminated intravascular coagulation (DIC) is a common complication in sepsis patients which exacerbates patient outcomes. The prevalence and outcomes of DIC in sepsis is wide-ranging and highly depends on the severity of the disease and diagnostic approaches utilized. Varied diagnostic criteria of DIC have been developed and their performance in diagnosis and prognosis is not consistent. Therefore, this study aimed to determine the score positivity rate and performance of different DIC scoring systems in predicting mortality in sepsis patients. METHODS: Four databases, including Medline (through PubMed), Scopus, Embase, and Web of Science were searched for studies that determined DIC in sepsis patients using the three scoring systems namely: the International Society on Thrombosis and Hemostasis DIC (ISTH-DIC) criteria, the Japanese association for acute medicine DIC (JAAM-DIC) criteria, and the sepsis-induced coagulopathy (SIC) criteria. A random-effect meta-analysis was performed with a 95% confidence interval (CI). Subgroup analysis was conducted in view of geographic region and sepsis stages. the protocol was submitted to the Prospective Register for Systematic Reviews (PROSPERO) with an identifier (CRD42023409614). RESULTS: Twenty-one studies, published between 2009 and 2024, comprising 9319 sepsis patients were included. The pooled proportion of cases diagnosed as positive using ISTH-DIC criteria, JAAM-DIC criteria, and SIC were 28% (95% CI: 24-34%), 55% (95% CI:42-70%), and 57% (95% CI: 52-78%), respectively. The pooled mortality rates were 44% (95% CI:33-53%), 37% (95% CI: 29-46%), and 35% (95% CI: 29-41%), respectively. The pooled sensitivity and specificity of ISTH-DIC to predict mortality were 0.43 (95% CI: 0.34-0.52), and 0.81 (95% CI: 0.74-0.87), respectively, while for JAAM-DIC it was 0.73 (95% CI: 0.57-0.85) and 0.46 (95% CI: 0.28-0.65), respectively. Pooled sensitivity and specificity for SIC were 0.71 (95% CI: 0.57-0.82) and 0.49 (95% CI: 0.31-0.66), respectively. CONCLUSION: The SIC and JAAM-DIC scores exhibited higher sensitivity to identify patients with coagulopathy and predict patient outcomes, and thus are valuable to identify patients for possible treatment at an early stage. The ISTH-DIC score perhaps identified patients at later stages and demonstrated better specificity to predict disease outcomes. Thus, early identification of patients using the SIC and JAAM-DIC scores and later confirmation using the ISTH-DIC score would be beneficial approach for improved management of patients with sepsis.